Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy

被引：0
作者：
Anna Rydén
Fiona Blackhall
Hye Ryun Kim
Rathi N. Pillai
Lauren Braam
Mona L. Martin
Andrew Walding
机构：
[1] AstraZeneca Gothenburg,Division of Molecular and Clinical Cancer Sciences
[2] University of Manchester,Department of Medical Oncology, Yonsei Cancer Center
[3] The Christie NHS Foundation Trust,Department of Hematology and Medical Oncology, School of Medicine
[4] Yonsei University College of Medicine,undefined
[5] Winship Cancer Institute of Emory University,undefined
[6] Health Research Associates Inc.,undefined
[7] AstraZeneca R&D,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2017年 / 10卷
关键词：
Epidermal Growth Factor Receptor; Initial Interview; Poor Appetite; Bothersome Symptom; Transcript Database;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：593 / 603
页数：10
相关论文
共 50 条
[41]   Comparison of Gefitinib in the treatment of patients with non-small cell lung cancer and clinical effects of Osimertinib and EGFR Gene mutation [J].
Li, Xiaofeng ;
Zhai, Zhanqiang ;
Zhu, Youcai ;
Zhou, Haiou .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (06) :1589-1594
[42]   Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations [J].
Wu, Jenn-Yu ;
Yu, Chong-Jen ;
Shih, Jin-Yuan .
CLINICAL LUNG CANCER, 2019, 20 (06) :E620-E630
[43]   Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR-mutated non-small-cell lung cancer [J].
Cheema, P. K. ;
Gomes, M. ;
Banerji, S. ;
Joubert, P. ;
Leighl, N. B. ;
Melosky, B. ;
Sheffield, B. S. ;
Stockley, T. ;
Ionescu, D. N. .
CURRENT ONCOLOGY, 2020, 27 (06) :321-329
[44]   Beyond Doublet Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Combination of Targeted Agents with First-Line Chemotherapy [J].
Herbst, Roy S. ;
Lynch, Thomas J. ;
Sandler, Alan B. .
CLINICAL LUNG CANCER, 2009, 10 (01) :20-27
[45]   Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines [J].
Dal Maso, Alessandro ;
Lorenzi, Martina ;
Ferro, Alessandra ;
Pilotto, Sara ;
Cecere, Fabiana ;
Follador, Alessandro ;
Polo, Valentina ;
Del Conte, Alessandro ;
Sartori, Giulia ;
Giavarra, Marco ;
Scattolin, Daniela ;
Indraccolo, Stefano ;
Frega, Stefano ;
De Maglio, Giovanna ;
Menis, Jessica ;
Bonanno, Laura ;
Calabrese, Fiorella ;
Guarneri, Valentina ;
Conte, PierFranco ;
Pasello, Giulia .
FUTURE ONCOLOGY, 2021, 17 (19) :2513-2527
[46]   A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer [J].
Tamura, Tomoki ;
Tani, Misaki ;
Ogata, Hiromichi ;
Osedo, Tomoya ;
Yamashita, Masahiro ;
Koyanagi, Taisaku ;
Nishi, Tatsuya ;
Umeno, Takahiro ;
Kuyama, Shoichi .
RESPIROLOGY CASE REPORTS, 2025, 13 (07)
[47]   Improvement in the survival of patients with stage IV non-small-cell lung cancer: Experience in a single institutional 1995-2017 [J].
Takano, Natsuki ;
Ariyasu, Ryo ;
Koyama, Junji ;
Sonoda, Tomoaki ;
Saiki, Masafumi ;
Kawashima, Yosuke ;
Oguri, Tomoyo ;
Hisakane, Kakeru ;
Uchibori, Ken ;
Nishikawa, Shingo ;
Kitazono, Satoru ;
Yanagitani, Noriko ;
Ohyanagi, Fumiyoshi ;
Horiike, Atsushi ;
Gemma, Akihiko ;
Nishio, Makoto .
LUNG CANCER, 2019, 131 :69-77
[48]   Amivantamab plus lazertinib vs. osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer [J].
Hasan, Nazmul ;
Nagasaka, Misako .
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2025, 19 (03) :223-232
[49]   Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy [J].
Takeda, M. ;
Okamoto, I. ;
Sakai, K. ;
Kawakami, H. ;
Nishio, K. ;
Nakagawa, K. .
ANNALS OF ONCOLOGY, 2012, 23 (11) :2931-2936
[50]   Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation [J].
Tanaka, Ichidai ;
Morise, Masahiro ;
Miyazawa, Ayako ;
Kodama, Yuta ;
Tamiya, Yutaro ;
Gen, Soei ;
Matsui, Akira ;
Hase, Tetsunari ;
Hashimoto, Naozumi ;
Sato, Mitsuo ;
Hasegawa, Yoshinori .
CLINICAL LUNG CANCER, 2020, 21 (03) :273-+
12345